| 发明名称 |
QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS |
| 摘要 |
This application provides for compounds of the formula Formula I or a pharmaceutically acceptable salt thereof, wherein the individual variables are defined herein, as well as processes to prepare these compounds, pharmaceutical compositions comprising the same and their use in treating disease state associated with the CRTH2 receptor.
|
| 申请公布号 |
US2013210805(A1) |
申请公布日期 |
2013.08.15 |
| 申请号 |
US201113878654 |
申请日期 |
2011.10.06 |
| 申请人 |
ASLANIAN ROBERT G.;BOYCE CHRISTOPHER W.;MAZZOLA, JR. ROBERT D.;MCKITTRICK BRIAN A.;MCCORMICK KEVIN D.;PALANI ANANDAN;QIN JUN;TANG HAIQUN;XIAO DONG;YU YOUNONG;CALDWELL JOHN P.;KELLEY ELIZABETH HELEN;ZHANG HONGJUN;SILIPHAIVANH PHIENG;MACCOSS RACHEL N.;METHOT JOEY L.;GAUUAN JOLICIA POLIVINA;JIANG QIN;LEYHANE ANDREW J.;BIJU JOHNY;DONG LI;HUANG XIAN;SHAO NING;ZHOU WEI;DHONDI PAWAN K. |
发明人 |
ASLANIAN ROBERT G.;BOYCE CHRISTOPHER W.;MAZZOLA, JR. ROBERT D.;MCKITTRICK BRIAN A.;MCCORMICK KEVIN D.;PALANI ANANDAN;QIN JUN;TANG HAIQUN;XIAO DONG;YU YOUNONG;CALDWELL JOHN P.;KELLEY ELIZABETH HELEN;ZHANG HONGJUN;SILIPHAIVANH PHIENG;MACCOSS RACHEL N.;METHOT JOEY L.;GAUUAN JOLICIA POLIVINA;JIANG QIN;LEYHANE ANDREW J.;BIJU JOHNY;DONG LI;HUANG XIAN;SHAO NING;ZHOU WEI;DHONDI PAWAN K. |
| 分类号 |
C07D239/91;A61K31/517;A61K31/5395;A61K31/55;A61K45/06;C07D401/10;C07D401/14;C07D403/10;C07D403/14;C07D405/10;C07D413/10;C07D413/14;C07D417/10;C07D471/04;C07D498/10 |
主分类号 |
C07D239/91 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
